Works matching DE "NON-small-cell lung carcinoma"
Results: 5000
Differential Characteristics on TCR Embedding Landscape Among Immune Checkpoint Blockade Responders Versus Non‐Responders Against Non‐Small Cell Lung Carcinoma.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202451374
- By:
- Publication type:
- Article
Repurposing bosentan as an anticancer agent: EGFR/ERK/c‐Jun modulation inhibits NSCLC tumor growth.
- Published in:
- Fundamental & Clinical Pharmacology, 2025, v. 39, n. 1, p. 1, doi. 10.1111/fcp.13052
- By:
- Publication type:
- Article
Preclinical studies on the antitumor and non‐toxic effect of combining pirfenidone with vinorelbine and carboplatin in non‐small cell lung cancer.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 9, p. 1756, doi. 10.1002/ijc.35276
- By:
- Publication type:
- Article
Estrogen, estrogen receptor and the tumor microenvironment of NSCLC.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 8, p. 1501, doi. 10.1002/ijc.35309
- By:
- Publication type:
- Article
Mediastinal staging lymph node probability map in non-small cell lung cancer.
- Published in:
- Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03121-z
- By:
- Publication type:
- Article
Correction: Unforeseen nodal upstaging in patients undergoing segmentectomy without frozen section: a multicenter retrospective cohort study.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Unforeseen nodal upstaging in patients undergoing segmentectomy without frozen section: a multicenter retrospective cohort study.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2025, v. 39, n. 4, p. 2296, doi. 10.1007/s00464-025-11612-9
- By:
- Publication type:
- Article
[<sup>18</sup>F]F-FAPI-42 PET dynamic imaging characteristics and multiparametric quantification of lung cancer: an exploratory study using uEXPLORER PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1685, doi. 10.1007/s00259-024-07064-3
- By:
- Publication type:
- Article
LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 1/2, p. 81, doi. 10.1080/14737140.2024.2305352
- By:
- Publication type:
- Article
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications.
- Published in:
- Expert Review of Clinical Immunology, 2024, v. 20, n. 8, p. 959, doi. 10.1080/1744666X.2024.2372327
- By:
- Publication type:
- Article
Safety of PD-L1 inhibitors versus PD-1 inhibitors in the treatment of lung cancer: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 3, p. 259, doi. 10.1080/14737140.2025.2465901
- By:
- Publication type:
- Article
The efficacy of Veliparib in combination with chemotherapy in the treatment of lung cancer: systematic review and meta-analysis.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1237, doi. 10.1080/14737140.2024.2417770
- By:
- Publication type:
- Article
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 9, p. 893, doi. 10.1080/14737140.2024.2373888
- By:
- Publication type:
- Article
First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR-mutated NSCLC: a meta-analysis of randomized phase III trials.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 775, doi. 10.1080/14737140.2024.2362889
- By:
- Publication type:
- Article
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 347, doi. 10.1080/14737140.2024.2344648
- By:
- Publication type:
- Article
Design, synthesis, and biological evaluation of evodiamine-indolequinone hybrids as novel NQO1 agonists against non-small cell lung cancer.
- Published in:
- Arabian Journal of Chemistry, 2025, v. 18, n. 1, p. N.PAG, doi. 10.1016/j.arabjc.2024.106075
- By:
- Publication type:
- Article
Tanshinone IIA affects the proliferation of A549/Tax by affecting the expression of MMP7 through the PI3K-AKT-mTOR signaling pathway.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02152-8
- By:
- Publication type:
- Article
A novel PAK1/TCF1 regulatory axis promotes non-small cell lung cancer progression.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02110-4
- By:
- Publication type:
- Article
Comparative Effectiveness of First‐Line Pembrolizumab vs. Chemotherapy in aNSCLC: A Norwegian Population‐Based Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1123, doi. 10.1002/cpt.3591
- By:
- Publication type:
- Article
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation.
- Published in:
- Drug Development Research, 2025, v. 86, n. 1, p. 1, doi. 10.1002/ddr.70036
- By:
- Publication type:
- Article
3,3′-diindolylmethane induces ferroptosis and inhibits proliferation in non-small-cell lung cancer through the AHR/NRF2/GPX4 axis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02096-z
- By:
- Publication type:
- Article
Ki-67 expression in anti-programmed cell death protein-1 antibody-bound CD8<sup>+</sup> T cells as a predictor of clinical benefit.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02060-x
- By:
- Publication type:
- Article
Patient-reported outcomes in non-small cell lung cancer: psychometric evaluation of the PROMIS PF-SF 8c and NSCLC-SAQ in two phase 3 clinical trials.
- Published in:
- Quality of Life Research, 2025, v. 34, n. 3, p. 751, doi. 10.1007/s11136-024-03846-2
- By:
- Publication type:
- Article
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer.
- Published in:
- Biomarker Research, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40364-025-00756-4
- By:
- Publication type:
- Article
ヒトiPS 細胞由来心筋細胞のミトコンドリア品質に 着目した抗がん薬による心毒性リスク評価
- Published in:
- Folia Pharmacologica Japonica, 2025, v. 160, n. 1, p. 9, doi. 10.1254/fpj.24056
- By:
- Publication type:
- Article
Predictive Value of the Lung Immune Prognostic Index for Immune Checkpoint Inhibitor Therapy Outcomes in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2025, v. 24, n. 2, p. 132, doi. 10.18502/ijaai.v24i2.18141
- By:
- Publication type:
- Article
Percutaneous transthoracic needle biopsy of lung lesions is a safe method associated with a very low risk of pleural recurrence.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2025, v. 169, n. 1, p. 21, doi. 10.5507/bp.2024.030
- By:
- Publication type:
- Article
Clinical characteristics and prognostic analysis of patients with SMARCA4-deficient lung cancer.
- Published in:
- Technology & Health Care, 2025, v. 33, n. 2, p. 1014, doi. 10.1177/09287329241296242
- By:
- Publication type:
- Article
Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1443609
- By:
- Publication type:
- Article
Metabolic pathway activation and immune microenvironment features in non-small cell lung cancer: insights from single-cell transcriptomics.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1546764
- By:
- Publication type:
- Article
Angiogenesis in Cancer.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2021, v. 42, n. 2, p. 168, doi. 10.1055/s-0041-1732849
- By:
- Publication type:
- Article
A Case Report of Primary Resistance to EGFR TKI in Lung Adenocarcinoma Due to Coexisting MET Exon 14 Skipping Mutation with Excellent Response to Combination of Gefitinib and Capmatinib.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2021, v. 42, n. 2, p. 204, doi. 10.1055/s-0041-1731851
- By:
- Publication type:
- Article
ALK Inhibitors in Nonsmall Cell Lung Cancer.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2021, v. 42, n. 1, p. 67, doi. 10.1055/s-0041-1729728
- By:
- Publication type:
- Article
Liquid Biopsy.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2021, v. 42, n. 1, p. 77, doi. 10.1055/s-0041-1729434
- By:
- Publication type:
- Article
Tumor Forkhead Box J2 as a Biomarker Reflecting Risks of Recurrence and Death in Non-Small Cell Lung Cancer Receiving Surgical Resection.
- Published in:
- Tohoku Journal of Experimental Medicine, 2024, v. 264, n. 4, p. 159, doi. 10.1620/tjem.2024.J059
- By:
- Publication type:
- Article
Current Biomarkers in Non-Small Cell Lung Cancer—The Molecular Pathologist's Perspective.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 5, p. 631, doi. 10.3390/diagnostics15050631
- By:
- Publication type:
- Article
A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 252, doi. 10.1002/cpdd.1500
- By:
- Publication type:
- Article
Real-World Data on Osimertinib-Associated Cardiac Toxicity.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1754, doi. 10.3390/jcm14051754
- By:
- Publication type:
- Article
The role of PD-L1 in EGFR-mutant non-small cell lung cancer.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02089-y
- By:
- Publication type:
- Article
Evaluating Different Anti-PD-1/PD-L1 Immunotherapies for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- International Journal of High School Research, 2025, v. 7, n. 2, p. 78, doi. 10.36838/v7i2.11
- By:
- Publication type:
- Article
PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer: a multicenter retrospective real-world study.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13868-9
- By:
- Publication type:
- Article
Deep learning radiomics for the prediction of epidermal growth factor receptor mutation status based on MRI in brain metastasis from lung adenocarcinoma patients.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13823-8
- By:
- Publication type:
- Article
Validation for revision of the stage IIIA(T1N2) in the forthcoming ninth edition of the TNM classification for lung cancer.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-024-13364-6
- By:
- Publication type:
- Article
Corrigendum: Exploring the impact of HDL and LMNA gene expression on immunotherapy outcomes in NSCLC: a comprehensive analysis using clinical & gene data.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Ensartinib as a neoadjuvant therapy for stage IIIA non-small cell lung cancer patients with EML4-ALK fusion: a case report and literature review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1474997
- By:
- Publication type:
- Article
Case Report: Grade 4 pneumonitis occurred after thoracic radiotherapy and dacomitinib in a patient with lung adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1436134
- By:
- Publication type:
- Article
Exploring the impact of HDL and LMNA gene expression on immunotherapy outcomes in NSCLC: a comprehensive analysis using clinical & gene data.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1448966
- By:
- Publication type:
- Article
Severe thyroiditis induced by sintilimab monotherapy in a patient with non-small cell lung cancer: a case report and literature review.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1548452
- By:
- Publication type:
- Article
Adagrasib in KRYSTAL-12 has Not Broken the KRAS G12C Enigma Code of the Unspoken 6-Month PFS Barrier in NSCLC.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 169, doi. 10.2147/LCTT.S492126
- By:
- Publication type:
- Article
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer.
- Published in:
- ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 55, doi. 10.2147/CEOR.S501532
- By:
- Publication type:
- Article